09.02.2024 - HBC had gross operating revenues of NOK 47.4m (33.6m) in the fourth quarter and NOK 218.5m (120.4m) for the full year. Adjusted for the sale of assets in the second quarter, operating revenues were NOK 194.9m for the full year, representing an .
27.11.2023 - Hofseth International AS, a close associate of Board member Roger Hofseth, has today agreed to acquire 435,207 shares in Hofseth BioCare ASA (the Company ). The shares are purchased at a price of NOK 2.80 per share. Following the transaction, .